Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed or Refractory Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03120676
What this trial is testing

Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center 3
Early research (Phase 1)Looking for participantsNCT06189391
What this trial is testing

Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101)

Who this might be right for
Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
MSD R&D (China) Co., Ltd. 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07713459
What this trial is testing

A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Who this might be right for
Lymphoma NonhodgkinMarginal Zone B Cell LymphomaDiffuse Large B Cell Lymphoma (DLBCL)+2 more
Kure Cells, INC 105
Very early researchLooking for participantsNCT04532203
What this trial is testing

CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaNon-Hodgkin's Lymphoma
Zhejiang University 72
Early research (Phase 1)Ended earlyNCT05169489
What this trial is testing

BbT369 in Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)
Regeneron Pharmaceuticals 15
Testing effectiveness (Phase 2)Study completedNCT00002982
What this trial is testing

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03144674
What this trial is testing

INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)

Who this might be right for
Lymphoma
Incyte Corporation 110
Not applicableStudy completedNCT00445731
What this trial is testing

A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Cancer
University of Minnesota 115
Not applicableUnknownNCT04447547
What this trial is testing

Clinical Trial of SL1904B CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Non-hodgkin's Lymphoma
Hebei Senlang Biotechnology Inc., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT00453206
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Wake Forest University Health Sciences 66
Testing effectiveness (Phase 2)Study completedNCT03792815
What this trial is testing

Busulfan, Melphalan and Etoposide as Conditioning for Autologous Transplantation for Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin's Lymphoma
Soonchunhyang University Hospital 51
Early research (Phase 1)Study completedNCT01403948
What this trial is testing

BI 836826 Dose Escalation in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL)

Who this might be right for
Lymphoma, Non-Hodgkin
Boehringer Ingelheim 48
Not applicableStudy completedNCT05422521
What this trial is testing

Radiomics and Metabolomics in the Follow-up of CAR T-cells for Refractory or Relapsed Non-Hodgkin's Lymphoma

Who this might be right for
Refractory or Relapsed Non-Hodgkin's Lymphoma
Centre Hospitalier Universitaire de Nice 20
Early research (Phase 1)Study completedNCT05216835
What this trial is testing

Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory Classical Hodgkin Lymphoma
AstraZeneca 45
Testing effectiveness (Phase 2)Ended earlyNCT02535247
What this trial is testing

Study of MK-3475 Alone or in Combination With Copanlisib in Relapsed or Refractory NK and T-cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, T-Cell, Peripheral
Fox Chase Cancer Center 17
Testing effectiveness (Phase 2)Study completedNCT00138164
What this trial is testing

Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Jonsson Comprehensive Cancer Center 50
Early research (Phase 1)Study completedNCT03029338
What this trial is testing

CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma

Who this might be right for
Lymphomas Non-Hodgkin's B-CellRelapse
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Study completedNCT01075321
What this trial is testing

Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+16 more
Mayo Clinic 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT01703949
What this trial is testing

Brentuximab Vedotin With or Without Nivolumab in Treating Patients With Relapsed or Refractory CD30+ Lymphoma

Who this might be right for
Recurrent Hodgkin LymphomaRecurrent Non-Hodgkin LymphomaRefractory Hodgkin Lymphoma+1 more
University of Washington 28
Next Page